Johnson & Johnson's nasal spray 'Spravato' approved for use by actively suicidal persons


Content Team
Image Credit: shortpedia

The United States Food and Drug Administration has approved Spravato, a nasal spray produced by American multinational corporation Johnson & Johnson, for use as an antidepressant for actively suicidal persons. Michelle Kramer, vice president of Johnson & Johnson’s US neuroscience medical-affairs unit, said the spray has been used by 6,000 individuals for treatment-resistant depression since its launch in March 2019.